How to Assess the Ageing Face: Anatomy, Examination, & Treatment Planning

Assessment Goals

The ageing face is not assessed by asking “what procedure does this patient need?”. It is assessed by deciding what is ageing, what is asymmetry, what is functional, and what the patient is actually asking to change.

Define the problem before the treatment

A safe assessment separates ageing mechanisms so treatment is not applied generically.

• Intrinsic ageing: thinning skin, reduced elasticity, rhytids, and slower tissue recovery.
• Volume loss: hollowing in temporal, periorbital, malar, perioral, or mandibular regions.
• Soft-tissue descent: brow, malar fat, jowl, platysma, and neck laxity.
• Skeletal support: maxillary, mandibular, dental, and chin support affecting apparent soft-tissue ageing.

Measure what will guide the plan

Baseline assessment should document both the patient’s satisfaction goals and objective severity so treatment effects can be judged later ¹.

• Quantitative baseline: use reproducible measurements where they affect operative design or durability assessment ².
• Skin and soft tissue: skin elasticity and dermal quality may be relevant outcome measures for ageing interventions ³.
• Anatomic priority: identify the main drivers of ageing so treatment restores facial balance rather than isolated features ⁴.
• Safety filter: choose interventions that prioritise patient safety before maximal rejuvenation or durability ⁵.

Convert concerns into treatable targets

The assessment should translate vague complaints into anatomical and functional findings.

• Upper-face lines: distinguish glabellar, lateral canthal, and horizontal forehead lines when botulinum toxin is being considered ⁶.
• Individual variation: account for sex, race, ethnicity, and baseline morphology because facial ageing differs between patients ⁴.
• Asymmetry: document pre-existing brow, eyelid, midface, mouth, and neck asymmetry before intervention.
• Function: identify visual field symptoms, exposure, airway, dental, speech, swallowing, or neck mobility concerns.

Facial Ageing Anatomy

Ageing anatomy matters because each tissue layer responds to a different treatment. Excision, lifting, filling, resurfacing, neuromodulation, and skeletal correction solve different problems.

Think in layers, not wrinkles

Treatment planning should map ageing changes to the five facial layers: skin, subcutaneous fat and retinacula, SMAS, deep fat, and periosteum or deep fascia ⁷.

• Skin: photodamage, pigment, fine rhytids, elastosis, texture change, and scar potential.
• Subcutaneous fat: compartment deflation, pseudoherniation, descent, and contour irregularity.
• SMAS-platysma: vector of lift, jowl formation, neck bands, and lower-face support.
• Deep support: deep fat, periosteum, retaining ligaments, and bony projection guide repositioning.

Separate deflation, descent, and deterioration

Assessment should consider skin, bone or cartilage, fat, and muscle as ageing structures rather than judging skin laxity alone ⁸.

• Deflation: temporal hollowing, tear trough, malar flattening, perioral hollowing, and prejowl sulcus.
• Descent: brow ptosis, malar descent, nasolabial deepening, jowling, and cervical laxity.
• Deterioration: crepey skin, dyschromia, solar elastosis, and poor recoil.
• Redistribution: bulging may occur in the submental region, jowls, infraorbital pouches, malar fat, and perioral folds ⁸.

Use retaining ligaments as both cause and warning

Retaining ligaments create transition zones, tethering, and safety landmarks. Operative planning should choose the dissection plane and ligament release according to the aesthetic goal while using retaining ligaments as nerve-safety landmarks ⁹.

• Tethering: ligaments contribute to tear trough, nasolabial fold, mandibular ligament, and neck contour changes.
• Release: incomplete release limits lift; over-release risks contour and nerve problems.
• Nerve safety: ligament zones often sit near facial nerve danger areas.
• Vector planning: lift should oppose descent while preserving natural facial expression.

Read the periorbital unit as one structure

The ageing periorbital region should be assessed as brow, eyelid, orbicularis, lid-cheek junction, and malar area together rather than isolated eyelid skin ¹⁰.

• Brow: ptosis, asymmetry, lateral hooding, and compensatory frontalis overactivity.
• Upper lid: dermatochalasis, true ptosis, hollowing, fat prolapse, and lash show.
• Lower lid: laxity, tear trough, fat prolapse, skin excess, and lid-cheek junction depth.
• Malar area: orbicularis or malar descent, crow’s feet, malar festoons, and cheek support ¹⁰.

Match regional anatomy to the complaint

Volume-deficient areas such as periorbital, temporal, malar, mandibular, mental, glabellar, and perioral regions should be assessed for restoration rather than only excision or lifting ⁸.

• Midface: assess cheek projection, malar deflation, ogee curve, and submalar hollow.
• Perioral: evaluate upper-lip length, vermilion show, and maxillary incisor show ².
• Lower face: assess prejowl hollow, jowl descent, marionette region, chin support, and mandibular border.
• Neck: assess submental fat, platysmal bands, skin laxity, hyoid position, and cervicomental angle.

History and Patient Factors

The consultation should reveal whether the patient is suitable for treatment, not only what bothers them. A technically possible intervention may still be unsafe, poorly timed, or psychologically inappropriate.

Start with goals and treatment history

The patient’s words should be translated into anatomical targets and realistic priorities.

• Main concern: ask what they want changed, what they want preserved, and what outcome would disappoint them.
• Prior procedures: record facelifts, blepharoplasty, rhinoplasty, fat grafting, implants, threads, or scars.
• Recent treatments: document retinoids, fillers, energy-based treatments, botulinum toxin, laser, peels, and dermabrasion because they affect assessment and treatment selection ¹¹.
• Timing: clarify upcoming events, recovery tolerance, and willingness for staged treatment.

Identify ageing exposures and medical risk

History should include intrinsic factors and extrinsic exposures such as ultraviolet radiation, air pollution, malnutrition, and smoking because these influence ageing and suitability ⁸.

• Sun exposure: ultraviolet (UV) radiation may contribute up to 80% of environmental facial ageing effects ⁸.
• Weight change: major loss worsens laxity; fluctuation reduces predictability.
• Medication risk: anticoagulants, immunosuppression, isotretinoin history, steroids, and photosensitising drugs matter.
• Frailty: older patients should be screened for frailty because it signals reduced stress tolerance and adverse outcome vulnerability ¹².

Screen psychological suitability deliberately

Body dysmorphic disorder should be screened for by the surgeon using a validated psychological tool rather than informal questioning alone ¹³.

• Clinical screen: cosmetic ageing-face patients should undergo a BDD screen before treatment planning ¹³.
• Validated tools: options include BDDQ, BDDQ-DV, BDDQ-AS, COPS, BDSS, and BDD-ST ¹³.
• Red flags: fixed dissatisfaction, mirror checking, multiple prior consultations, social avoidance, and disproportionate distress.
• Decision point: defer treatment if motivation, expectations, or psychological safety is unclear.

Systematic Facial Examination

The examination should be structured enough that another clinician can understand the deformity, reproduce the assessment, and follow the treatment logic.

Begin globally before narrowing regionally

A systematic assessment should examine the face globally as well as by region because adjacent areas, muscle tone, subcutaneous tissue, and skin thickness interact ¹⁴.

• Position: assess in natural head position, centric relation, and relaxed lip posture ¹⁵.
• Views: examine front, oblique, profile, basal, and close-up regional views.
• Balance: compare upper, middle, and lower facial thirds, projection, width, and facial shape.
• Pattern: classify the dominant ageing pattern as deflation, tissue deterioration, descent, or combination ⁴.

Examine the skin as a treatment target

Skin examination should distinguish colour, surface, thickness, elasticity, and tolerance.

• Photoageing: document fine wrinkles, coarse wrinkles, roughness, hyperpigmentation, and tolerability factors ¹⁶.
• Surface: assess smoothness, scaliness, and wrinkles because these can be measured as treatment-response outcomes ¹¹.
• Quality: skin colour, elasticity, and radiance may be recorded when evaluating topical response ¹¹.
• Scarring risk: note keloid tendency, dyspigmentation risk, thin skin, rosacea, and active dermatitis.

Work from the upper face to the neck

Use the same order each time so subtle asymmetry and functional findings are not missed.

• Brow and forehead: brow height, tail position, frontalis compensation, glabellar strength, and forehead lines.
• Eyelids: dermatochalasis, ptosis, lid laxity, scleral show, fat prolapse, hollowing, and exposure symptoms.
• Midface: cheek projection, flattened ogee curve, and submalar concavity should be assessed specifically ⁴.
• Lower face and neck: nasolabial fold, perioral rhytids, jowls, platysma bands, submental fullness, and skin excess.

Separate static, dynamic, and functional findings

Animation often reveals the true driver of the patient’s concern.

• Static findings: ptosis, skin excess, fat prolapse, hollowing, and asymmetry at rest.
• Dynamic findings: corrugator, orbicularis, mentalis, depressor anguli oris, and platysma activity.
• Functional eyelids: visual obstruction, brow compensation, lagophthalmos, dry eye, and lid malposition.
• Facial nerve: document weakness, synkinesis, smile asymmetry, and platysmal imbalance.

Use objective grading when it changes decisions

Facial examination should not rely only on subjective impressions; objective or standardised scoring should be used where available ¹⁴.

• Wrinkle grading: match wrinkles to reference photographs and assign a 0–5 grade when useful ¹.
• Infraorbital hollow: a 5-point photonumeric scale can assess hollowing across sex, age, and skin type ¹⁷.
• Brow position: eyebrow tail position should be measured when periorbital ageing treatment effect is being evaluated ¹⁰.
• Patient impact: record the regions affecting appearance and psychosocial function when volume treatment is being considered ¹⁸.

Documentation and Photography

Good documentation protects the patient and clinician. It also turns aesthetic assessment into a measurable baseline rather than a memory of the consultation.

Standardise the photographic set

Baseline and follow-up photography should be standardised enough to permit serial measurements at meaningful intervals ¹⁴.

• Core views: frontal, right and left oblique, right and left profile, and close regional views.
• Set-up: consistent camera distance, lens, lighting, background, head position, and facial expression.
• Hair and make-up: expose hairline, ears, jawline, eyelids, and neck where relevant.
• Serial comparison: record baseline and post-treatment assessments to compare outcomes over time ¹⁶.

Capture animation and function where relevant

Static photographs are insufficient when the complaint is dynamic or functional.

• Animation views: frown, smile, brow elevation, eye closure, lip repose, and neck contraction.
• Eyelid function: document ptosis, brow compensation, scleral show, lagophthalmos, and dry eye symptoms.
• Asymmetry: record pre-existing brow, eyelid, cheek, mouth, jawline, and neck asymmetry.
• Skeletal traits: document reproducible facial-skeletal traits so baseline findings inform planning and later care ¹⁵.

Record measurements and scales selectively

Objective documentation can use skin microtopography for surface parameters and 3-dimensional imaging for gross lifting effects ¹¹.

• Perioral ageing: ratios, caliper measurements, or 3-dimensional measurements may be recorded ².
• Glabellar lines: maximum frown severity can be graded on a defined 0–3 scale from clinician and patient perspectives ⁶.
• Validated scales: use validated assessment scales when tracking clinical change after treatment ¹⁶.
• Baseline design: quantitative baseline measurements can guide operative design and later durability assessment ².

Assessment-Based Treatment Planning

The plan should follow the diagnosis. Avoid treating every ageing face with the same filler, device, resurfacing treatment, or operation.

Match the treatment category to the dominant finding

Treatment should target the specific ageing elements identified on assessment rather than applying a single standard approach ⁸.

Use non-surgical options for the right deformity

Non-surgical treatments are strongest when the target is skin quality, dynamic muscle activity, mild laxity, or volume deficit.

• Skin laxity: mild-to-moderate laxity suits microfocused ultrasound better than advanced laxity ¹⁴.
• Severe laxity: counsel toward surgical options rather than microfocused ultrasound alone ¹⁴.
• Modest improvement: radiofrequency is better suited to patients seeking modest rather than dramatic rejuvenation ¹⁹.
• Skin findings: skin colour, elasticity, and radiance can guide topical or skin-quality treatment choices ¹¹.

Treat volume and laxity as different problems

A full face is not necessarily a lifted face, and a lifted face is not necessarily restored.

• Fat compartments: minimally invasive planning should identify superficial and deep fat compartments and boundaries for safety and effectiveness ⁷.
• Volume restoration: reduced elasticity, wrinkles, or volume loss may make PLLA or CaHA biostimulators relevant options ²⁰.
• HA planning: patients should understand that 12-week volume maintenance varies by region, with lower maintenance reported in lips than malar or midface regions ¹⁸.
• Layered ageing: skin, bone or cartilage, fat, and muscle should all be considered before selecting a single treatment category ⁸.

Escalate when surgery solves the actual problem

Surgery becomes more appropriate when the finding is structural descent, skin excess, herniated fat, functional eyelid impairment, or advanced neck laxity.

• Brow and eyelid: distinguish brow ptosis, dermatochalasis, lid ptosis, and fat prolapse before offering blepharoplasty.
• Midface and lower face: choose lifting when descent and ligamentous laxity dominate over isolated deflation.
• Upper lip: balance the longer-lasting lift of surgery against scar inevitability and the more conservative effect of non-surgical methods ².
• Planning posture: confirm natural head position, centric relation, and relaxed lip posture before final facial planning ¹⁵.

Counselling and Suitability

Counselling should make the plan safer and more realistic. The patient should understand what the assessment found, what treatment can change, and what it cannot change.

Set realistic expectations before consent

Facial rejuvenation improves selected features; it does not stop ageing or create perfect symmetry.

• Psychosocial motivation: explore perceived ageing concerns because facial ageing can affect self-perception and social interactions ⁴.
• Volume treatment: large-volume HA filler treatment has been associated with improved patient-reported appearance and psychosocial domains ¹⁸.
• Regional durability: midface correction may maintain volume better than mimetic areas through 12 weeks ¹⁸.
• Staging: combine treatments only when sequencing, recovery, and risk remain understandable.

Discuss treatment-specific risk honestly

Consent should be specific to the planned intervention, not a generic aesthetic warning.

• Botulinum toxin: pooled cosmetic glabellar and forehead botulinum toxin A complication rate was 16% across 4268 sessions ²¹.
• Upper-face toxin: headache or migraine, bruising or haematoma, and facial neuromuscular symptoms were reported in 6.3%, 3.8%, and 3.3% of sessions respectively ²¹.
• Microfocused ultrasound: bruising, dysaesthesia, burns, striae, and papules were reported in 2% of treated patients ¹⁴.
• Biostimulators: PLLA and CaHA most often caused mild injection-site pain and swelling in reported studies ²⁰.

Explain maintenance and longevity

Patients should know whether they are choosing a temporary, maintenance-based, staged, or surgical strategy.

• Biostimulator duration: reported durability differs, with PLLA lasting up to 25 months and CaHA 12 to 18 months ²⁰.
• Treatment burden: periorbital PRP regimens averaged three sessions at mean 23-day intervals in published studies ²².
• Topical care: topical treatments require adherence and usually suit texture, pigment, and fine-rhytid goals.
• Surgery: scars, recovery, revision risk, and ongoing ageing should be discussed before listing.

Know when to defer or decline

Suitability is a clinical decision, not a customer preference.

• BDD risk: patients seeking facial ageing treatment should be screened because BDD is common in cosmetic settings and may be missed ²³.
• Prevalence context: weighted BDD prevalence was 13.2% in general cosmetic surgery and 9.2% in cosmetic dermatology outpatients ²³.
• Medical deferral: uncontrolled disease, smoking risk, unsafe medication status, or frailty may outweigh aesthetic benefit.
• Expectation mismatch: decline treatment when the requested change is anatomically impossible, unsafe, or unlikely to satisfy.

References